CoChat

Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines

Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., Abrahamsson, P.‐A. · 2004 · The Prostate
Cited by 154

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Increase in the number of serotonin (5‐HT) releasing neuroendocrine (NE) cells has been shown to be correlated with tumor progression, loss of androgen dependence, and poor prognosis. Serotonin is a well‐known mitogen which mediates a wide variety of physiological effects via multiple receptors, of which receptor subtype 1 (5‐HTR1) has been identified in prostate cancer (PC) cell lines. Recently, 5‐HT has been found to show growth‐promoting activity and to be functionally related to oncogenes. MATERIALS AND METHODS: Localization, protein content, and mRNA expression of 5‐HTR subtype 1A, 1B, and 1D was studied in prostatic tissue (35 patients), metastases, PC cell lines, a benign prostatic stromal cell line (human prostate cell preparation (hPCP)), and xenografts of PC‐3 cells by immunohistochemistry (IHC), Western blotting, and RT‐PCR, respectively. The growth‐inhibition effect of a 5‐HT1A antagonist (NAN‐190) on PC cell lines was studied using a bromodeoxyuridine (BrdU) assay. RESULTS: A strong immunoreaction of 5‐HTR1A and 1B was demonstrated in high‐grade tumor cells (35/35) and a small number of BPH cells, whereas 5‐HTR1D was confined to vascular endothelial cells. 5‐HTR1A was also demonstrated in PC cells metastasized to lymph node and bone, PC‐3, DU145, LNCaP, and in xenografts of PC‐3 cells and hPCP. Western blot analysis gave strong bands from PC tissue extracts compared to BPH tissue. Using RT‐PCR, 5‐HTR1A mRNA was demonstrated in all PC cell lines. An antagonist of 5‐HTR1A (NAN‐190) inhibited the growth of PC‐3, DU145, and LNCaP cells but not of hPCP cells. CONCLUSIONS: This is the first study demonstrating an overexpression of 5‐HTR subtypes 1A and 1B in PC cells, especially in high‐grade tumors. Moreover, 5‐HT stimulates proliferation of PC cells and 5‐HTR1A antagonists inhibit proliferation. Thus, we propose that 5‐HT has an important role in tumor progression, especially in the androgen‐independent state of the disease. The design of specific antagonists for this type of receptor might be useful for the growth control of androgen‐independent tumors. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.10374

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Endocrine cells in human intestine: an immunocytochemical study

    Sjölund, K., Sandén, G., Håkanson, R., & Sundler, F. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80080-8 · Cited by 520 · cited 1×

    “It is well established that 5-HT is produced and stored in several tissues throughout the body, including the central nervous system (CNS) [8] and blood platelets [9], but also in gastrointestinal enterochromaffin cells [10] and prostatic NE cells [4], and that 5-HT plays a fundamental role in regulation of growth, di…”
    Background

Show all 1 references

Cited by

See all 154

Metadata

Authors
Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., & Abrahamsson, P. ‐.
Venue
The Prostate
Publisher
Wiley
Published
2004-01-05
Volume
59
Issue
3
Pages
328-336
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W1969909043
Cited by
154
References
1
FWCI
5.47
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. https://app.cochat.ai/papers/10.1002/pros.10374
The paper
Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., & Abrahamsson, P. ‐. (2004). Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. The Prostate. https://doi.org/10.1002/pros.10374

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.